Cargando…
Hepatitis C Virus and Antiviral Drug Resistance
Since its discovery in 1989, hepatitis C virus (HCV) has been intensively investigated to understand its biology and develop effective antiviral therapies. The efforts of the previous 25 years have resulted in a better understanding of the virus, and this was facilitated by the development of in vit...
Autores principales: | Kim, Seungtaek, Han, Kwang-Hyub, Ahn, Sang Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087927/ https://www.ncbi.nlm.nih.gov/pubmed/27784846 http://dx.doi.org/10.5009/gnl15573 |
Ejemplares similares
-
Casein Kinase II Inhibitor Enhances Production of Infectious Genotype 1a Hepatitis C Virus (H77S)
por: Kim, Seungtaek, et al.
Publicado: (2014) -
Emerging Therapies for Hepatitis C
por: Kim, Do Young, et al.
Publicado: (2014) -
Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
por: Kim, Kyung-Ah, et al.
Publicado: (2023) -
Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011) -
Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
por: Kim, Do Young, et al.
Publicado: (2013)